X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com//news-release/2023/09/21/2747160/0/en/SIKLOS-hydroxyurea-is-now-covered-by-State-Medicaid-programs-in-19-states.html
https://www.prnewswire.com/news-releases/european-medicines-agency-approves-oxbryta-voxelotor-first-treatment-approved-in-the-eu-to-target-the-cause-of-sickle-cell-disease-301490103.html
https://www.globenewswire.com/news-release/2022/01/27/2374009/37049/en/Positive-Early-Access-to-Medicines-Scheme-EAMS-Scientific-Opinion-Awarded-to-GBT-s-Voxelotor-for-the-Treatment-of-Haemolytic-Anaemia-Due-to-Sickle-Cell-Disease.html
http://www.pharmafile.com/news/600609/positive-chmp-opinion-sickle-cell-disease-anaemia-tablet
http://www.pharmatimes.com/news/nice_turns_down_novartis_adakveo_1358458
https://www.novartis.com/news/media-releases/novartis-sickle-cell-medicine-adakveo-approved-europe-prevent-recurrent-vaso-occlusive-crises
https://www.prnewswire.com/news-releases/siklos-the-first-and-only-hydroxyurea-based-treatment-for-pediatric-patients-with-sickle-cell-anemia-now-available-in-100-mg-scored-tablets-to-help-further-optimize-dosing-301154297.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213438
http://www.pharmatimes.com/news/revolutionary_liquid_sickle_cell_treatment_unveiled_1314539
https://www.prnewswire.com/news-releases/siklos-the-first-and-only-hydroxyurea-based-treatment-for-pediatric-patients-with-sickle-cell-anemia-now-available-in-retail-pharmacies-300699627.html
http://www.nasdaq.com/article/novartis-announces-positive-data-on-sickle-cell-disease-drug-cm890716
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2009975
Market Place
Share 
